INMD
Undervalued by 90.4% based on the discounted cash flow analysis.
Market cap | $1.43 Billion |
---|---|
Enterprise Value | $687.78 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $2.3 |
Beta | 0.0 |
Outstanding Shares | 83,982,462 |
Avg 30 Day Volume | 1,571,156 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 7.22 |
---|---|
PEG | 15.6 |
Price to Sales | 3.43 |
Price to Book Ratio | 1.9 |
Enterprise Value to Revenue | 1.4 |
Enterprise Value to EBIT | 3.52 |
Enterprise Value to Net Income | 3 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ('RF') technology. InMode strives to enable new emerging surgical procedures as we...